Ami Organics Limited Stock

Equities

AMIORG

INE00FF01017

Diversified Chemicals

Delayed NSE India S.E. 01:59:23 2024-04-26 am EDT 5-day change 1st Jan Change
1,215 INR -0.57% Intraday chart for Ami Organics Limited +1.92% +8.38%
Sales 2024 * 7.13B 85.6M Sales 2025 * 8.89B 107M Capitalization 45.08B 541M
Net income 2024 * 555M 6.66M Net income 2025 * 1.08B 13M EV / Sales 2024 * 6.32 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 5.07 x
P/E ratio 2024 *
68.7 x
P/E ratio 2025 *
41.4 x
Employees 602
Yield 2024 *
-
Yield 2025 *
-
Free-Float 43.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.51%
1 week+1.92%
Current month+11.18%
1 month+8.21%
3 months+6.16%
6 months+7.79%
Current year+8.38%
More quotes
1 week
1 176.00
Extreme 1176
1 247.30
1 month
1 080.95
Extreme 1080.95
1 296.50
Current year
1 004.45
Extreme 1004.45
1 296.50
1 year
1 004.45
Extreme 1004.45
1 388.95
3 years
766.10
Extreme 766.1
1 434.45
5 years
766.10
Extreme 766.1
1 434.45
10 years
766.10
Extreme 766.1
1 434.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 04-01-02
Director of Finance/CFO 46 22-03-23
Chief Operating Officer 48 -
Members of the board TitleAgeSince
Director/Board Member 58 21-04-27
Chief Executive Officer 49 04-01-02
Founder 50 04-01-02
More insiders
Date Price Change Volume
24-04-26 1,215 -0.57% 121 346
24-04-25 1,222 +0.48% 106,602
24-04-24 1,216 +0.75% 253,928
24-04-23 1,207 +2.07% 180,926
24-04-22 1,183 -0.85% 112,952

Delayed Quote NSE India S.E., April 26, 2024 at 01:59 am EDT

More quotes
Ami Organics Limited is an India-based manufacturer of specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). It manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. It has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The Company supplies its products to more than 150 customers directly in India and to approximately 25 countries overseas.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,222 INR
Average target price
1,298 INR
Spread / Average Target
+6.20%
Consensus
  1. Stock Market
  2. Equities
  3. AMIORG Stock